✦ LIBER ✦

Expression of Major Histocompatibility Complex Class I Antigens as a Strategy for the Potentiation of Immune Recognition of Tumor Cells

✍ Scribed by Kenichi Tanaka, Hiroaki Hayashi, Chuya Hamada, George Khoury and Gilbert Jay

Book ID: 123634008
Publisher: National Academy of Sciences
Year: 1986
Tongue: English
Weight: 703 KB
Volume: 83
Category: Article
ISSN: 0027-8424
DOI: 10.2307/29127

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of human major histocompatibi

Evaluation of human major histocompatibility complex class I chain-related A as a potential target for tumor imaging

✍ Bixia Tang; Zhi Yang; Jie Huang; Zhiyong Hao; Wenjing Li; Lianxian Cui; Wei He 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 591 KB

Inhibition of Major Histocompatibility C

Inhibition of Major Histocompatibility Complex Class I Antigen Shedding Up-Regulates the Surface Expression of Class I Antigens on the Lymphocyte Cell Surface

✍ A. GUHA; N. DAINIAK; R. E. CONE 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

Up-regulation of the expression of major

Up-regulation of the expression of major histocompatibility complex class I antigens by plasmid DNA transfection in non-hematopoietic cells

✍ Joo-Hung Park; Sun-Hee Chang; Min-Chul Kim; Sung-Hye Shin; Hyun-Joo Youn; Jin-Ky 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Listeriolysin generates a route for the

Listeriolysin generates a route for the presentation of exogenous antigens by major histocompatibility complex class I

✍ Ayub Darji; Trinad Chakraborty; Jürgen Wehland; Siegfried Weiss 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 585 KB

The effect of photodynamic therapy on tu

The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules

✍ Alan Belicha-Villanueva; Jonah Riddell; Naveen Bangia; Sandra O. Gollnick 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB

## Abstract ## Background and Objective Photodynamic therapy (PDT) is FDA‐approved anti‐cancer modality for elimination of early disease and palliation in advanced disease. PDT efficacy depends in part on elicitation of a tumor‐specific immune response that is dependent on cytotoxic T lymphocytes

Reduction of major histocompatibility co

Reduction of major histocompatibility complex class I expression on bladder carcinoma following tumor antigen-pulsed dendritic cell vaccine: Implications for immunoresistance in therapy

✍ Mengqiang Li; Huili Wang; Zhijun Xi; Enci Xu; Xuejun Jiang; Jiangying Chen; Wenz 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB